Discounted Cash Flow (DCF) Analysis Levered
MDxHealth SA (MDXH.BR)
0.339 €
-0.00 (-1.17%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 28.40 | 11.79 | 18.37 | 22.24 | 37.05 | 44.93 | 54.49 | 66.08 | 80.13 | 97.17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -28.54 | -22.29 | -20.24 | -22.55 | -34.12 | -53.32 | -64.66 | -78.41 | -95.08 | -115.30 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -1.35 | -0.07 | -0.54 | -0.90 | -4.16 | -2.12 | -2.57 | -3.11 | -3.77 | -4.58 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -29.89 | -22.36 | -20.78 | -23.44 | -38.28 | -55.43 | -67.22 | -81.52 | -98.85 | -119.87 |
Weighted Average Cost Of Capital
| Share price | $ 0.339 |
|---|---|
| Beta | 0.864 |
| Diluted Shares Outstanding | 120.84 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | 15.44% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 7.887 |
| Total Debt | 39.79 |
| Total Equity | 40.97 |
| Total Capital | 80.76 |
| Debt Weighting | 49.27 |
| Equity Weighting | 50.73 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 28.40 | 11.79 | 18.37 | 22.24 | 37.05 | 44.93 | 54.49 | 66.08 | 80.13 | 97.17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.54 | -22.29 | -20.24 | -22.55 | -34.12 | -53.32 | -64.66 | -78.41 | -95.08 | -115.30 |
| Capital Expenditure | -1.35 | -0.07 | -0.54 | -0.90 | -4.16 | -2.12 | -2.57 | -3.11 | -3.77 | -4.58 |
| Free Cash Flow | -29.89 | -22.36 | -20.78 | -23.44 | -38.28 | -55.43 | -67.22 | -81.52 | -98.85 | -119.87 |
| WACC | ||||||||||
| PV LFCF | -49.67 | -53.96 | -58.63 | -63.70 | -69.21 | |||||
| SUM PV LFCF | -295.18 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 11.61 |
| Free cash flow (t + 1) | -122.27 |
| Terminal Value | -1,272.30 |
| Present Value of Terminal Value | -734.64 |
Intrinsic Value
| Enterprise Value | -1,029.82 |
|---|---|
| Net Debt | 24.29 |
| Equity Value | -1,054.11 |
| Shares Outstanding | 120.84 |
| Equity Value Per Share | -8.72 |